Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study

John Busby; Ken Mills; Shu-Dong Zhang; Fabio Giuseppe Liberante; Chris R. Cardwell

doi:10.1186/s13058-017-0928-0

Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study

John Busby, Ken Mills, Shu-Dong Zhang, Fabio Giuseppe Liberante, Chris R. Cardwell

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Breast Cancer Research
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s13058-017-0928-0
Publication status	Published (in print/issue) - 19 Jan 2018

Keywords

Selective serotonin reuptake inhibitors
Breast cancer
Progression
Survival
Pharmacoepidemiology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13058-017-0928-0

Cite this

@article{a41a201ebc1a4c8ca5d0d20dca0e182c,

title = "Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study",

keywords = "Selective serotonin reuptake inhibitors, Breast cancer, Progression, Survival, Pharmacoepidemiology",

author = "John Busby and Ken Mills and Shu-Dong Zhang and Liberante, {Fabio Giuseppe} and Cardwell, {Chris R.}",

year = "2018",

month = jan,

day = "19",

doi = "10.1186/s13058-017-0928-0",

language = "English",

volume = "20",

journal = "Breast Cancer Research",

issn = "1465-542X",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study

AU - Busby, John

AU - Mills, Ken

AU - Zhang, Shu-Dong

AU - Liberante, Fabio Giuseppe

AU - Cardwell, Chris R.

PY - 2018/1/19

Y1 - 2018/1/19

KW - Selective serotonin reuptake inhibitors

KW - Breast cancer

KW - Progression

KW - Survival

KW - Pharmacoepidemiology

U2 - 10.1186/s13058-017-0928-0

DO - 10.1186/s13058-017-0928-0

M3 - Article

C2 - 29351761

SN - 1465-542X

VL - 20

JO - Breast Cancer Research

JF - Breast Cancer Research

IS - 1

ER -